Phase II

During phase II, the REDI-NET program will generate evidence through two levels of laboratories to evaluate three hypotheses using descriptive analyses that informed improvement in forecasting potential risk of exposure for local communities. Gold labs include the University of Notre Dame, the Naval Medical Research Center, and the Walter Reed Biosystematics Unit. Silver labs consist of the Belize Vector and Ecology Center (Belize), the Navy Entomology Center of Excellence (USA), and the Mpala Research Centre (Kenya). Inclusion of external partnerships will enable expansion of the pathogen portfolio through opportunistic sampling.

The hypotheses to be evaluated during phase II: 

  1. Expansion of pathogen portfolio to include vertebrate DNA
  2. Validation of the e-MERGE pipeline
  3. Knowledge transfer to key CONUS and OCONUS stakeholders

Phase II Study Design

Phase Ii Study Design